This year’s celebration honoured 10 exemplary individuals, including a Chancellor Emeritus and a Distinguished Professor Emeritus.

Congratulations to all the 2025 honourees.

Chancellor Emeritus

Chancellor Dave Angus and President Michael Benarroch present Anne Mahon with certificate for Chancellor Emeritus.

Ms. Anne Mahon served with distinction as the University’s 14th Chancellor from 2019 to 2025, where she brought compassion, wisdom, and a deep commitment to community to her role. A bridge-builder and philanthropist, Ms. Mahon is known for connecting people and inspiring positive change. Her work at the intersection of storytelling, community-building, and education has amplified the voices of those marginalized and often unheard.

Ms. Mahon has dedicated herself to volunteerism and advocacy, including working closely with United Way Winnipeg, founding and facilitating the Bookmates Book Club at the Women’s Correctional Centre, and volunteering with the Immigrant and Refugee Community Organization of Manitoba, Humankind International, and Palliative Manitoba. Her leadership and compassion have left an enduring mark on the University of Manitoba, thereby earning the title of Chancellor Emeritus.

Distinguished Professor Emeritus

Chancellor Dave Angus and President Michael Benarroch present Leslie Roos with certificate for Distinguished Professor Emeritus.

The University of Manitoba was honoured to confer upon Dr. Leslie Roos the title of Distinguished Professor Emeritus. An influential scholar and innovative leader in population health and health policy research, Dr. Roos joined the University of Manitoba in 1973. Over the course of his distinguished career in the Faculties of Administrative Studies (now the Asper School of Business) and Medicine, he helped establish the university as an international centre of excellence in health services research and data-informed policy.

As a founder of the Manitoba Centre for Health Policy, Dr. Roos led the creation of its internationally respected population health database, enabling groundbreaking studies on the health and well-being of Manitobans. He has played a central role in training and inspiring a generation of researchers whose work continues to shape Canadian health systems and stands among the most influential contributors to health policy research globally.

Professor Emeriti:

• Dr. Harold Aukema
• Dr. Ying Chen
• Dr. Kevin Coombs
• Prof. Herbert Enns
• Dr. Elissavet Kardami
• Dr. Eberhard Renner
• Dr. Wayne Simpson
• Dr. Qiang Zhang

To learn more about the 2025 honourees, please visit the Emeritus/Emerita Titles webpage to read their individual citations.

Emeriti titles are one of several awards given annually by the university in celebrating and recognizing the success of colleagues and other distinguished individuals. Learn about the university awards nomination process.

This four year program is aimed at supporting outstanding individuals from diverse backgrounds, empowering them to pursue higher education and become future leaders in international development. This collaborative effort between the University of Nairobi (Kenya) (UoN) and the University of Manitoba demonstrates a commitment to fostering education and development in their countries in the area of medical microbiology and infectious diseases.

The University of Manitoba and University of Nairobi have collaborated in this area since 1979. Scientists from both institutions have become world experts in HIV/AIDS, sexually transmitted infections, vaccinology and clinical trials. For over thirty years there have been reciprocal training exchanges which have seen UoN trainees obtain PhDs at the UM and then return to UoN to take on prominent roles. Past trainees have gone on to chair the department of medical microbiology and immunology, and serve at the director level with the Kenyan AIDS Vaccine Initiative – Institute for Clinical Research (KAVI-ICR) Director, and the Institute for Tropical and Infectious Diseases (UNITID).

Dr. Keith Fowke, department head and professor in medical microbiology and infectious diseases at the Max Rady College of Medicine says: “This is an exciting opportunity to enhance the 43-year relationship between the the University of Manitoba and the University of Nairobi by providing Kenyan research trainees with the skills that they can bring back Kenya to drive research and innovation which will benefit their home country.

The BCDI 2030 Scholarship Program will not only offer financial assistance but will also provide mentorship, research opportunities, and networking events to enhance the overall educational experience for the recipients which will equip scholars with the skills and knowledge necessary to address complex global challenges.

“As the Dean of the Faculty of Graduate Studies, I am excited to witness the transformative impact these scholarships will have on the lives of talented individuals who will undoubtedly become leaders in health research.” says Kelley Main.

Additional information on the program can be found on the Universities Canada website.

Last week, the World Health Organization classified EG.5 as a variant of interest, but said it does not seem to pose more of a threat to public health than other variants.

According to virologist Jason Kindrachuk, this strain is an Omicron subvariant that doesn’t deviate much from what we’ve already seen.

Read here

Listen here

“We are proud to promote research and development of innovative ideas essential for economic development through this diverse funding platform that demonstrates innovation, talent and collaboration in Manitoba,” said Karen Dunlop, CEO of Research Manitoba.

“UM researchers are leading the way with new advancements in information technology and healthcare services with potential to improve lives, here in Manitoba and worldwide,” said Dr. Mario Pinto, vice-president (research and international). “I congratulate these researchers on achieving this vital support to bring these game-changing concepts into reality.”

Dr. Ji Hyun Ko

Dr. Marcus Ng

Ji Hyun Ko and Marcus Ng, departments of human anatomy and cell science and internal medicine (section of neurology), Rady Faculty of Health Sciences: A real-time electroencephalography-guided non-invasive brain stimulation to suppress epileptic seizures.

The Ko and Ng research team has developed a new non-invasive brain stimulation treatment that can reduce the impacts of epileptic seizure “spikes.” This breakthrough has significantly improved the patient intensive care discharge rate from 37 per cent to 90 per cent. This new project seeks to further optimize this for use in patients’ homes and develop a prototype wearable system called the “Ictopauser.”

Using stimulation parameters tailored for each patient based on a comprehensive treatment database, Ictopauser will suppress spikes in real time as patients sleep. The Ictopauser has the potential to save lives and will bring peace of mind to the 65 million people worldwide who live with epilepsy.

Dr. Denice Bay

Denice Bay, department of medical microbiology and infectious diseases, Rady Faculty of Health Sciences, with industry partner PerioDiagnostics Inc.: Rapid point of care strip test development to detect periodontal gum disease bacterial by-products in saliva.

Periodontal disease is a form of bacterial gum disease affecting seven in 10 Canadians over the age of 45 that causes damage to gum and bones, leading to tooth loss and serious infections. Despite being such a common condition, periodontal disease is difficult to diagnose using current tools.

Bay, in partnership with the company Periodiagnostics Inc., will undertake a two-year project to test dyes capable of detecting the bacteria responsible quickly and accurately at the point-of-care. To achieve this, saliva from volunteers with and without periodontal disease will be collected at Winnipeg dental clinics, with the outcome being a ready-to-distribute test kit for use by dental professionals and community clinics.

Dr. Puyan Mojabi

Puyan Mojabi, department of electrical and computer engineering, Price Faculty of Engineering: Reconfigurable Electromagnetic Metasurfaces for Smart Radio Environments

This new research project by Puyan Mojabi, Canada Research Chair in Electromagnetic Inversion for Characterization and Design, seeks to improve wireless communications. This is motivated by the fact that current wireless infrastructure is heavily taxed in attempts to fill demands for higher performance, data transfer rates and security requirements. To this end, Mojabi aims to create new software to facilitate the precise design of reconfigurable thin panels, known as electromagnetic metasurfaces.

These reconfigurable panels, resembling thin poster frames, can be strategically used to tailor the environment between transmitters and receivers. The resulting “smart radio environment” then provides an extra degree of design freedom to allow users to define improved wireless service specifications.

CRCs are world leaders in their field funded by the Government of Canada in the areas of natural sciences and engineering, health sciences, and social sciences and humanities. “These symposia were a wonderful opportunity for researchers to get to know each other’s specialties, and to spark new collaborations with students and the wider community,” says Mario Pinto, Vice-President (Research and International). “I thank all the CRCs for their groundbreaking contributions to address the issues faced by society today.”

This thought-provoking look at current UM research is available to view online, each featuring a brief presentation from the gathered CRCs followed by a question-and-answer period with the audience.

CRC Symposium 1, February 2, 2023 – Fort Garry Campus

Featuring presentations from: Heather Armstrong, Chair in Integrative Bioscience; Guozhen Zhu, Chair in Mechanical and Functional Design of Nanostructured Materials; Trust Beta, Chair in Grain-Based Functional Foods; Eric Collins, Chair in Arctic Marine Microbial Ecosystem Services; Britt Drögemöller, Chair in Pharmacogenomics & Precision Medicine; Ned Budisa, Chair in Chemical Synthetic Biology and Xenobiology; Lori Wilkinson, Chair in Migration Futures; Jason Kindrachuk, Chair in Epidemiology and Global Public Health; Sabine Mai, Chair in Genomic Instability and Nuclear Architecture in Cancer; Jörg Stetefeld, Chair in Structural Biology and Biophysics; Carl Ho, Chair in Efficient Utilization of Electric Power; and Nandika Bandara, Chair in Food Proteins.

CRC Symposium 2, February 27, 2023 – Bannatyne Campus

Featuring presentations from: Tracie Afifi, Chair in Childhood Adversity and Resilience; Robert Lorway, Chair in Global Intervention Politics and Social Transformation; Janilyn Arsenio, Chair in Systems Biology of Chronic Inflammation; Puyan Mojabi, Chair in Electromagnetic Inversion for Characterization and Design; Annette Desmarais, Chair in Human Rights, Social Justice and Food Sovereignty; Zulma Rueda, Chair in Program Sciences & Global Public Health; and Kathryn Sibley, Chair in Integrated Knowledge Translation in Rehabilitation Sciences.

CRC Symposium 3, March 28, 2023 – Fort Garry Campus

Featuring presentations from: Ties Boerma, Chair in Population and Global Health; Kiera Ladner, Chair in Miyo we’citowin, Indigenous Governance & Digital Sovereignties; Rotimi Aluko, Chair in Bioactive Peptides; Zahra Moussavi, Chair in Biomedical Engineering; Terry Klassen, Chair in Clinical Trials; and Galen Wright, Chair in Neurogenomics.

CRC Symposium 4, April 24, 2023 – Bannatyne Campus

Featuring presentations from: Lisa Lix, Chair in Methods for Electronic Health Data Quality; John Ataguba, Chair in Health Economics; Nicole Wilson, Chair in Arctic Environmental Change and Governance; Lorrie Kirshenbaum, Chair in Molecular Cardiology; Meghan Azad, Chair in Developmental Origins of Chronic Disease; and Kristine Cowley, Chair in Function and Health after Spinal Cord Injury.

CRC Symposium 5, May 16, 2023 – Fort Garry Campus

Featuring presentations from: Kristina Brown, Chair in Arctic Marine Biogeochemistry; Nicole Rosen, Chair in Language Interactions; Robert Mizzi, Chair in Queer, Community & Diversity Education; Samar Safi-Harb, Chair in Extreme Astrophysics; and Susan Logue, Chair in Cell Stress and Inflammation.

CRC Symposium 6, June 19, 2023 – Bannatyne Campus

Featuring presentations from: Andrew Halayko, Chair in Chronic Lung Disease Pathobiology and Treatment; Colin Gilmore, Chair in Applied Electromagnetic Inversion; James Blanchard, Chair in Epidemiology and Global Public Health; Marcelo Urquia, Chair in Applied Population Health; and Souradet Shaw, Chair in Program Science & Global Public Health.

Dr. Erica Charters, professor of the global history of medicine at the University of Oxford .

can resume? What are the markers of an epidemic’s end, and who has the insight, authority, and credibility to decipher these signs?

Join Dr. Erica Charters Professor of the Global History of Medicine at the University of Oxford for a lecture and discussion on the ends of epidemics. This talk will draw on insights from the multidisciplinary project, How Epidemics End, that she directed at the University of Oxford.

What: How Epidemics End
When: March 20, 2023
6:00 PM – 8:00 PM (CT)

Location: Robert B. Schultz Lecture Theatre
University of Manitoba – Fort Garry Campus
Winnipeg MB

This lecture is funded by the Robin Connor Lectureship in the History and Philosophy of Science. UM is thrilled to be hosting the lecture series on campus for the first time in five years.

This event is free to attend, but we ask that you register in advance. 

Register

How Epidemics End Abstract

What does it mean for an epidemic to end, and who gets to declare that it is over? Although the outset of an epidemic is often marked by official declarations, endings are messy and contentious, often raising issues of competing authority. Who defines the end to an epidemic, and what data and information should be used to measure its end? This talk will discuss the research findings of the University of Oxford’s multidisciplinary project on How Epidemics End, which began in 2020.

The project examines the ways in which various epidemics have ended, comparing and contrasting different diseases, regions, and time periods. It also brings together over 30 researchers from different fields: anthropologists, ecologists, epidemiologists, historians, mathematical modellers, and philosophers, among others. Scholars discussed the ways in which they measure and define an epidemic’s end, sharing insights through workshops, online interviews, and an open-access special journal issue published in 2022.

The project’s early findings caution that, `contrary to popular assumption and idealistic hope, epidemics do not generally end through the abrupt eradication of a disease or the quick administration of a vaccine.’ In the project’s framework article published in January 2021, historians Erica Charters and Kristin Heitman instead point out that most often `an epidemic is declared to have ended once the disease falls to endemic levels, when it becomes an accepted, manageable part of normal life.’ Yet, this raises the issue of what it means for disease to be at ‘acceptable’ levels, and who should decide this. More generally, epidemics end at different times for different groups, both across regions and within one society. As a result, analyzing the process of ending `reveals the nature of epidemics as social and political events, and not simply biological phenomena.’

`How Epidemics End’ therefore examines how different researchers understand, assess, and measure epidemics and their endings. Epidemiologists measure the ending of epidemics differently than international health organizations; likewise, historians and anthropologists measure the ending according to the resumption of normal social and cultural practices, whereas mathematical modellers and epidemiologists chart it by declines in disease rates. In the project’s series of online videos, experts discuss their research into past and current epidemics. The first three videos, for example, compare how different researchers study cholera and its endings, from England in the nineteenth century to the current cholera epidemic in Yemen. These illustrate the different methodologies researchers use to gauge and define the endings of epidemics — even when studying the same disease.

`How Epidemics End’ reveals that health officials, researchers, and the general public understand epidemics differently at the breakout and end stages; and that only by understanding how an epidemic has ended can the origin and course of the outbreak can be fully understood.

A second, academic lecture –“Excess Death: Counting the Costs of Eighteenth-Century War, Disease, and Empire”— will take place at 3:00 p.m. on March 21, in 200 Fletcher Argue Lecture Theatre. In this lecture, Dr. Charters will examine the rise of statistical approaches in assessing modern crises such as wars and epidemics. It will outline how European experiences of colonial war and disease encouraged numeracy and spread early forms of quantitative analyses through army reports, health surveys, slavery records, and population censuses.

Biography.

Dr. Erica Charters, Professor of the Global History of Medicine,
Faculty of History, Academic Lead, Medical Humanities

Dr. Charters’s research examines the history of war, disease, and bodies, particularly in the British and French empires. In the context of COVID-19, Dr. Charters coordinated a multidisciplinary project on How Epidemics End, and co-edited a special issue, ‘Histories of Epidemics in the Time of Covid-19’. Her research focuses on manpower during the eighteenth century, examining the history of bodies as well as the history of methods used to measure and enhance bodies, labour, and population as a whole, including the history of statistics. Since disease was the biggest threat to manpower in the early modern world, she analyses how disease environments — throughout the world —shaped military, commercial, and agricultural power, as well as how overseas experiences shaped European theories of medicine, biology, and race alongside political methodologies such as statistics and censuses. She is co-founded of the multi-disciplinary research group ‘Body Counts: War Losses and Casualties’, which researches the history and methods of identifying casualties and losses in war.

Dr. Charters’s monograph Disease, War, and the Imperial State: The Welfare of British Armed Forces during the Seven Years War, Chicago, 2014) traces how responses to disease shaped military strategy, medical theory, and the nature of British imperial authority (awarded the AAHM 2016 George Rosen Prize and the SAHR 2014 Best First Book). As well as coordinating the Oxford and Empire project  she is on the executive committees of the Navy Records Society and the Society for the History of War. Dr. Charters is also on the editorial boards of the British Journal of Military History, Centaurus (the journal of the European Society for the History of Science), and War Studies.

The Gairdner Awards recognize some of the world’s most significant biomedical and global health research and discoveries.  This award recognizes Dr. Dick’s discovery and characterization of leukemic stem cells, providing insights into the understanding, diagnosis, and treatment of acute myeloid leukemia.

As the Gairdner award states: 

The work:
Dr. John Dick made the first discovery of leukemia stem cells (LSC) in acute myeloid leukemia (AML) patients. This finding established that individual cancer cells in the patient are not equal, rather they are organized as a cellular hierarchy where only rare leukemia cells possess self-renewal, the hallmark stem cell property. This discovery required two experimental components that Dick developed: a xenograft assay to detect LSC based on their ability to generate human leukemia upon transplantation into immune-deficient mice and a method to purify leukemia cells into LSC and non-LSC populations. By combining functional LSC assays with genetic analysis, Dick tracked the complex evolutionary pathways of human leukemia development from normal blood stem cells to pre-leukemic stem cells that eventually generate LSC and AML up to a decade later. This work also showed that LSCs that can cause later relapse have already evolved prior to diagnosis and can survive normal therapy procedures. Thus, LSC was directly linked to therapy failure and relapse in leukemia patients. The properties of LSC as reflected in their gene expression are predictive of therapy response and overall survival. Dick developed a 17-gene ‘stemness score’ that can be used clinically to determine the patient’s risk of poor outcome and help guide therapeutic choice.

The impact:
Dick’s discovery of LSC changed the understanding of the underlying biology of cancer and stimulated the exploration of cancer stem cells (CSCs) in other human cancers, including those affecting the breast, brain, colon, pancreas, skin, and liver. His work highlighted the importance of investigating the properties of individual cells of the neoplastic clone, rather than bulk cancer cells and that special attention needs to be on the CSC which are the only cells capable of long-term cancer propagation. The focus on CSC is revealing a number of properties that enable their survival in the face of therapy including dormancy, stress signaling as well as stemness programs that enable disease recurrence. Dick’s work points to the need to ensure that CSC are eradicated when therapy is delivered and the need for new therapies that target CSC vulnerabilities. The discovery that pre-leukemic stem cells are present many years prior to disease appearance and that relapse-fated LSC are already present at diagnosis both offer windows of opportunity to target pre-leukemia and relapse earlier to prevent disease and relapse from occurring, respectively. Dick’s findings offer clear direction for improving clinical outcomes in leukemia through LSC targeting and potentially in other cancers that adhere to the CSC model.

About the Gairdner Foundation

The Gairdner Foundation was established in 1957 by Toronto stockbroker, James Gairdner to award annual prizes to scientists whose discoveries have had major impact on scientific progress and on human health. Since 1959 when the first awards were granted, 402 scientists have received a Canada Gairdner Award and 96 to date have gone on to receive the Nobel Prize. The Canada Gairdner Awards promote a stronger culture of research and innovation across the country through our outreach programs including lectures and research symposia. The programs bring current and past laureates to universities across Canada to speak with faculty, trainees and high school students to inspire the next generation of researchers. Annual research symposia and public lectures are organized across Canada to provide Canadians access to leading science through Gairdner’s convening power. Gairdner is supported nationally by the Government of Canada.

Read the full media release.

Here’s why you should tune in to this dynamic competition:

Learn new things

The 3MT presentations are designed to challenge graduate students to take their complex ideas and research and formulate them in such a way that they are easy for audiences and judges to digest without prior education on the subject. From microbiology to physiology to pharmacology, the diverse areas of research represented at this year’s 3MT finals offer a smörgåsbord of stimulating topics and fascinating perspectives to satisfy any casual viewer’s curiosity.

Get inspiration

Feeling an inspiration block? The 3MT final presentations are bursting with innovative ideas and inspiring work from creative thinkers across the university community. Take advantage of this opportunity to get ideas for your own research, future studies, and more. You never know where your next inspiration will come from!

Support UM students

Every year, the 3MT finalists work tirelessly to put their presentations together and effectively articulate their ideas for a broad audience. Show your support for your UM community by watching some of the university’s brightest graduate students explain their passion projects!

Help choose the winner

Being an audience member at the 3MT final also involves participation! Once all the finalists have presented, audience members will have the opportunity to vote for the winner of the People’s Choice award. Your vote could be the difference!

CTV News Winnipeg’s Colleen Bready [BA(Adv)/03] will host the online competition. Students will be judged on comprehension, engagement, ease of communication by the judging panel which includes the Honorable Jon Reyes, Minister of Advanced Education, Skills and Immigration; Coleen Rajotte [BA(Adv)/89], Artistic Director of the Winnipeg Aboriginal Film Festival and CEO, Vitality Television; and Mark Evans [PhD/88], President & CEO of Conquest Planning Inc.

2022 3MT Final
Thursday, April 7
7:00 – 8:30pm

Watch live online

2022 Three Minute Thesis finalists

Alekhya Lavu – Pharmacy
Thesis: Antiseizure treatments during pregnancy and neonatal birth outcomes.​

Alexander Araujo – Natural Resources Institute
Thesis: Impacts of restoration: assessing if grazing by reintroduced plains bison affects bird abundance and diversity in Banff National Park.​

Chioma Victoria Nwachukwu – Physiology and Pathophysiology
Thesis: Electrical stimulation improves walking and organ function after spinal cord injury: but how?​

Chitra Sivakumar – Biosystems Engineering
Thesis: Non destructive analysis of pulse flours.​

Daniel Schwade Araujo – Applied Health Sciences
Thesis: Examining the associations between different physical fitness phenotypes and cardiovascular risk factors in older females.​

Jhannelle Francis – Microbiology
Thesis: Waterways (or rivers) as vehicles of enteric viruses.​

Kaitlynn Weisgerber – Biological Sciences
Thesis: Investigating spontaneous autopolyploidy in wild and hatchery lake sturgeon.​

Olya Myhalatyuk – Pharmacology and Therapeutics
Thesis: Shining light on microglia responses in Alzheimer’s disease.​

Pranav Mishra – Pharmacology and Therapeutics
Thesis: Potential of sex hormone estrogen in prevention of Alzheimer’s disease – a sex based study.​

Ryan Ha – Medical Microbiology and Infectious Diseases
Thesis: Development of a new method for studying Legionella infections.​

Shayna Giesbrecht – Microbiology
Thesis: Molecular detection and quantification of the prevalence of sexually transmitted blood-borne infections in Canadian waste water samples.​

Weiang Yan – Physiology and Pathophysiology
Thesis: New immuno-engineered biomaterials to prevent rejection of transplanted hearts.​

Representing a wide array of some of the most inspiring and engaging research being conducted by graduate students at UM, last week’s 3MT online heats featured 33 challengers who were tasked with explaining their intricate research studies to a judging panel comprised of members from the UM and Winnipeg community in just three minutes.

The 3MT Final will take place on April 7, and students, staff, faculty and the wider community are encouraged to watch the competition online, cheer on the 3MT finalists and learn about a wide range of innovative research in a dynamic competitive format.

The finalists – both master’s and doctoral students – will compete for the Dr. Archie McNicol Prize for First Place ($2,500), the UM Retirees Association Prize for Second Place ($1,250) and Third Place ($750).

The online audience will vote for the People’s Choice award (UM Bookstore gift certificate), so be sure to join live and vote for your favourite presentation!

The winner of the 3MT Final will advance to the Western Canada regional competition on May 6 and have the chance to be featured in a non-competitive showcase of 3MT videos from graduate students across Canada.

3MT is an annual competition where challengers have just three minutes to present their research and its importance in plain language, using only a single slide to illustrate their topic. The competitors are judged on comprehension, engagement, ease of communication all while providing an understanding of the background and significance of their research.

Everyone is invited to attend the online event and cheer on the finalists.

2022 3MT Final
Thursday, April 7
7:00 – 8:30pm

Viewing details will be posted here on the Faculty of Graduate Studies’ 3MT site.

2022 Finalists

Alekhya Lavu – Pharmacy
Thesis: Antiseizure treatments during pregnancy and neonatal birth outcomes.​

Alexander Araujo – Natural Resources Institute
Thesis: Impacts of restoration: assessing if grazing by reintroduced plains bison affects bird abundance and diversity in Banff National Park.​

Chioma Victoria Nwachukwu – Physiology and Pathophysiology
Thesis: Electrical stimulation improves walking and organ function after spinal cord injury: but how?​

Chitra Sivakumar – Biosystems Engineering
Thesis: Non destructive analysis of pulse flours.​

Daniel Schwade Araujo – Applied Health Sciences
Thesis: Examining the associations between different physical fitness phenotypes and cardiovascular risk factors in older females.​

Jhannelle Francis – Microbiology
Thesis: Waterways (or rivers) as vehicles of enteric viruses.​

Kaitlynn Weisgerber – Biological Sciences
Thesis: Investigating spontaneous autopolyploidy in wild and hatchery lake sturgeon.​

Olya Myhalatyuk – Pharmacology and Therapeutics
Thesis: Shining light on microglia responses in Alzheimer’s disease.​

Pranav Mishra – Pharmacology and Therapeutics
Thesis: Potential of sex hormone estrogen in prevention of Alzheimer’s disease – a sex based study.​

Ryan Ha – Medical Microbiology and Infectious Diseases
Thesis: Development of a new method for studying legonella infections.​

Shayna Giesbrecht – Microbiology
Thesis: Molecular detection and quantification of the prevalence of sexually transmitted blood-borne infections in Canadian waste water samples.​

Weiang Yan – Physiology and Pathophysiology
Thesis: New immuno-engineered biomaterials to prevent rejection of transplanted hearts.​